Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avichai Shimoni

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Blood Advances|January 8, 2025
Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cellsInbal Sdayoor, Roni Shouval, Shalev Fried, et al.
Blood Cancer Journal|November 20, 2019
Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMTAvichai Shimoni, Myriam Labopin, Jürgen Finke, et al.
Biochemical Pharmacology|July 21, 2019
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulatorsKatia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2018
Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related MortalityRoni Shouval, Cornelis N de Jong, Joshua Fein, et al.
Annals of Hematology|March 6, 2014
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphomaAbraham Avigdor, Tsvi Sirotkin, Meirav Kedmi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 PathwayKatia Beider, Evgenia Rosenberg, Hanna Bitner, et al.
American Journal of Hematology|June 21, 2017
Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioningAvichai Shimoni, Luca Vago, Massimo Bernardi, et al.
Blood Cancer Journal|May 13, 2021
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMTMaria H Gilleece, Avichai Shimoni, Myriam Labopin, et al.
Hematological Oncology|May 27, 2026
Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World StudyBen Varon, Ron Ram, Avichai Shimoni, et al.
Bone Marrow Transplantation|January 11, 2024
Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot studyIlan Youngster, Adi Eshel, Mika Geva, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Blood Advances|January 8, 2025
Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cellsInbal Sdayoor, Roni Shouval, Shalev Fried, et al.
Blood Cancer Journal|November 20, 2019
Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMTAvichai Shimoni, Myriam Labopin, Jürgen Finke, et al.
Biochemical Pharmacology|July 21, 2019
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulatorsKatia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2018
Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related MortalityRoni Shouval, Cornelis N de Jong, Joshua Fein, et al.
Annals of Hematology|March 6, 2014
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphomaAbraham Avigdor, Tsvi Sirotkin, Meirav Kedmi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 PathwayKatia Beider, Evgenia Rosenberg, Hanna Bitner, et al.
American Journal of Hematology|June 21, 2017
Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioningAvichai Shimoni, Luca Vago, Massimo Bernardi, et al.
Blood Cancer Journal|May 13, 2021
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMTMaria H Gilleece, Avichai Shimoni, Myriam Labopin, et al.
Hematological Oncology|May 27, 2026
Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World StudyBen Varon, Ron Ram, Avichai Shimoni, et al.
Bone Marrow Transplantation|January 11, 2024
Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot studyIlan Youngster, Adi Eshel, Mika Geva, et al.
Pageof 17